Concepedia

Mike A. Clark

MA

Statistics

Publications

50

Citations

3.2K

H-Index

28

Active since

1977

Affiliations

University of Kentucky(Current)

University of Pennsylvania

The University of Texas Southwestern Medical Center

Acceleron Pharma (United States)

The University of Texas Health Science Center at Houston

Mike A. Clark is an author at University of Kentucky specializing in pharmacology, life sciences, and medicine.

Publications per year

1977–2019

50

Publications

50

Incidence and distribution of argininosuccinate synthetase deficiency in human cancers

Brian J. Dillon, Víctor G. Prieto, Steven A. Curley et al. · Cancer · 2004 · 337 citations

Medicine, Cancer Biology, Oncology +17

Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.

Mark Ensor, Frederick W. Holtsberg, John S. Bomalaski et al. · PubMed · 2002 · 319 citations

Life Sciences, Biochemistry, Oncology +15

Pegylated Arginine Deiminase Treatment of Patients With Metastatic Melanoma: Results From Phase I and II Studies

Paolo A. Ascierto, Stefania Scala, Giuseppe Castello et al. · Journal of Clinical Oncology · 2005 · 249 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +16

Pegylated Arginine Deiminase Treatment of Patients With Unresectable Hepatocellular Carcinoma: Results From Phase I/II Studies

Francesco Izzo, Paolo Marra, Gerardo Beneduce et al. · Journal of Clinical Oncology · 2004 · 249 citations

Medicine, Oncology, Pharmacology +17

Mitochondrial transformation of mammalian cells

Mike A. Clark, Jerry W. Shay · Nature · 1982 · 217 citations

Life Sciences, Biology, Cell Biology +8

1–5 of 50